Vertex Pharmaceuticals, Inc. (VRTX)
439.59
+0.88
(+0.20%)
USD |
NASDAQ |
Apr 06, 10:56
Vertex Pharmaceuticals Total Liabilities (Quarterly) : 7.477B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| Amgen, Inc. | 81.93B |
| Moderna, Inc. | 3.688B |
| Eli Lilly & Co. | 85.94B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.14B |
| Shareholders Equity (Quarterly) | 18.67B |
| Debt to Equity Ratio | 0.1091 |
| Current Ratio | 2.901 |
| Net Debt Paydown Yield | -0.06% |